Renaissance Technologies
PRVA icon

Renaissance Technologies’s Privia Health PRVA Stock Holding History

Renaissance Technologies’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Sell
632,700
-143,800
-19% -$3.33M 0.02% 804
2026
Q1 		$16M Buy
776,500
+262,500
+51% +$5.92M 0.03% 745
2025
Q4 		$12.2M Sell
514,000
-62,300
-11% -$1.52M 0.02% 824
2025
Q3 		$14.3M Sell
576,300
-2,800
-0.5% -$60.3K 0.02% 893
2025
Q2 		$13.3M Buy
579,100
+268,700
+87% +$6.22M 0.02% 903
2025
Q1 		$6.97M Buy
310,400
+92,300
+42% +$2.14M 0.01% 1218
2024
Q4 		$4.26M Sell
218,100
-48,200
-18% -$955K 0.01% 1546
2024
Q3 		$4.85M Buy
266,300
+201,800
+313% +$3.85M 0.01% 1459
2024
Q2 		$1.12M Buy
+64,500
New +$1.14M ﹤0.01% 2259
2023
Q3 		– Sell
-132,409
Closed -$3.46M – 4008
2023
Q2 		$3.46M Sell
132,409
-328,600
-71% -$8.68M 0.01% 1638
2023
Q1 		$12.7M Buy
461,009
+75,100
+19% +$1.98M 0.02% 961
2022
Q4 		$8.76M Buy
385,909
+238,709
+162% +$6.64M 0.01% 1168
2022
Q3 		$5.01M Buy
147,200
+18,800
+15% +$695K 0.01% 1439
2022
Q2 		$3.74M Buy
128,400
+74,300
+137% +$1.89M ﹤0.01% 1766
2022
Q1 		$1.45M Buy
+54,100
New +$1.28M ﹤0.01% 2464

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Renaissance Technologies's PRVA Position: Q2 2026 in Review

Renaissance Technologies reduced its Privia Health (PRVA) stake by 19% in Q2 2026, selling an estimated $3.33M and leaving 632,700 shares worth $16.3M. The position accounts for 0.02% of the portfolio, ranked #804.

Renaissance Technologies first reported a position in PRVA in Q1 2022 and has held it in 15 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Renaissance Technologies held 632,700 shares of Privia Health worth $16.3M as of Q2 2026.
  • Renaissance Technologies sold 143,800 Privia Health shares in Q2 2026, an estimated $3.33M.
  • Privia Health made up 0.02% of Renaissance Technologies's portfolio in Q2 2026, its #804 holding.
  • Renaissance Technologies first reported a position in Privia Health in Q1 2022 and has held it in 15 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.